4
Changes in Ownership
Tarsus Pharmaceuticals, Inc. Filed Acc 0001841401-26-000003
Options or other derivatives
- General Counsel acquired 44,471 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Derivatives | |||||||
| Wahl Bryan General Counsel | 2026-03-05 | Grant or award · Stock Option (right to buy) | +27,310 | 27,310 | D | ||
| Wahl Bryan General Counsel | 2026-03-05 | Grant or award · Restricted Stock Units | +17,161 | 17,161 | D | ||
Loading xslF345X05/wk-form4_1773086812.xml…